Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

The semi-finals of Manx Hockey Association’s men’s and women’s cup, plate and bowl competitions took place on Saturday, with ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Okta Inc (NASDAQ:OKTA) shares are trading higher Tuesday on the heels of the company's better-than-expected financial results. Multiple analysts also upgraded the stock and raised price targets ...

Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga ...

Find insight on lithium, lumber, the impact of tariffs and more in the latest Market Talks covering Basic Materials.

Q4 2024 Earnings Call Transcript March 3, 2025 Quantum-Si incorporated misses on earnings expectations. Reported EPS is ...

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the ...

NuScale Power Corporation (NYSE: SMR) Q4 2024 Earnings Call Transcript March 3, 2025 NuScale Power Corporation beats earnings expectations. Reported EPS is $0.6, expectations were $-0.11.

Analysts at Canaccord Genuity reiterated their 135.0p target price on airside solutions developer Aurrigo International on ...